caa a22 4500 606183817 CHVBK 20210128100823.0 cr unu---uuuuu 210128e20150701xx s 000 0 eng 10.1007/s00405-014-3120-5 doi (NATIONALLICENCE)springer-10.1007/s00405-014-3120-5 Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients [Elektronische Daten] [Haim Gavriel, Adrian Tang, Ephraim Eviatar, Sor Chan] Thyroid incidentaloma detected on FDG-PET scan has been reported repeatedly in the last several years, though conflicting data are reported. Our aim is to identify the incidence and outcome of incidental FDG-PET detected thyroid lesions in patients undergoing FDG-PET scan for other primary malignancies and to suggest a management algorithm. This is a retrospective review of all patients who had a FDG-PET detected incidental thyroid lesion between January 2002 and December 2009 at Peter MacCallum Cancer Center. Demographics, data relating to PET scan findings, FNA diagnoses, operative details, and histopathology were reviewed. Of the 1,034 subjects who underwent the FDG-PET study, 51 (4.9%) were identified as having thyroid incidentaloma, 31 females and 20 males with a mean age of 60years. Thyroid malignancy was noted in 39.5% (19/48 patients) who underwent FNAB. Sixteen underwent thyroidectomy. The histopathology revealed 12 patients with papillary carcinoma, 5 with follicular carcinoma and 2 with medullary carcinoma. The high rates are in concordance with analysis of the rates published in the literature. In patients with thyroid PET incidentaloma, the incidence of primary thyroid malignancy is very high as reported in our study and based on analysis of published data, necessitating further investigation. If assessment of these incidentalomas suggests malignancy, then appropriate surgical management may be warranted according to the patient's medical condition. Springer-Verlag Berlin Heidelberg, 2014 PET nationallicence Thyroid nationallicence Incidentaloma nationallicence Outcome nationallicence Gavriel Haim Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut Tang Adrian Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut Eviatar Ephraim Department of Otolaryngology Head and Neck Surgery, Assaf Harofeh Medical Center, 70300, Zerifin, Israel aut Chan Sor Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut European Archives of Oto-Rhino-Laryngology Springer Berlin Heidelberg 272/7(2015-07-01), 1763-1768 0937-4477 272:7<1763 2015 272 405 https://doi.org/10.1007/s00405-014-3120-5 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s00405-014-3120-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Gavriel Haim Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut NATIONALLICENCE 700 1- Tang Adrian Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut NATIONALLICENCE 700 1- Eviatar Ephraim Department of Otolaryngology Head and Neck Surgery, Assaf Harofeh Medical Center, 70300, Zerifin, Israel aut NATIONALLICENCE 700 1- Chan Sor Department of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia aut NATIONALLICENCE 773 0- European Archives of Oto-Rhino-Laryngology Springer Berlin Heidelberg 272/7(2015-07-01), 1763-1768 0937-4477 272:7<1763 2015 272 405